PRKCA and cancer: This manifested that PAB could reverse the multidrug resistance to cancer cells via down-regulating Cox-2-PKC-α-P-gp/MDR1 signal pathway (Wong et al., 2005; Liu et al., 2012; Sun and Li, 2014b; Yu F. et al., 2015).